News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major market-moving headlines were published in the past hour.
  • Equity, bond, and FX markets lacked fresh catalysts during the hour.
  • No significant economic data releases occurred in the past hour.
  • No central bank or fiscal policy announcements were made during the hour.
  • No new geopolitical developments or major diplomatic actions were reported.
  • Traders stayed in wait-and-see mode ahead of upcoming scheduled data and events.

Latest Articles

First Solar Looks Vulnerable — Short the Hype, Trade the Facts

First Solar Looks Vulnerable — Short the Hype, Trade the Facts

First Solar (FSLR) still trades like a growth story despite weakening top-line trends, policy uncertainty and legal noise. At roughly $174, the stock is trading at ~10.7x trailing earnings and an EV/FCF north of 11x while quarterly revenue is contracting. We downgrade to a short-rated swing trade: entry $174.35, target $145.00, stop $190.00, horizo…

Coherent at a Crossroads: Cautious Buy on a Datacenter Growth Wave

Coherent at a Crossroads: Cautious Buy on a Datacenter Growth Wave

Coherent's datacenter-driven revenue surge and new photonics demos position it to capture a growing slice of AI infrastructure spending. The stock has run hard; we rate it a cautious buy with a clear entry at $295.00, stop at $275.00 and target at $360.00. Trade plan spans short, mid and long horizons with explicit exit rules and risk controls.

Oncolytics Biotech® Announces Publication Demonstrating Pelareorep Creates Immune Responses in Liver Cancer That Make Tumors Susceptible to Immunotherapy

Oncolytics Biotech® Announces Publication Demonstrating Pelareorep Creates Immune Responses in Liver Cancer That Make Tumors Susceptible to Immunotherapy

Oncolytics Biotech announced published data demonstrating that its investigational immunotherapy pelareorep can convert immunologically inactive (cold) liver cancer tumors into immunologically active (hot) tumors, potentially making them more responsive to immune-based therapies. The publication highlights pelareorep's ability to upregulate inflamm…

Decent Holding’s SunCare Launches AI-Powered In-Home Senior Care Service Through Strategic Collaboration with Ruilan International

Decent Holding’s SunCare Launches AI-Powered In-Home Senior Care Service Through Strategic Collaboration with Ruilan International

Decent Holding Inc. (NASDAQ: DXST) announces the launch of its AI-powered in-home senior care service by its SunCare business, starting with an RMB 500 monthly Essential Health Management subscription. This rollout leverages SunCare's estimated 200,000 paid-member base and introduces a three-tier subscription framework designed to extend community-…

Columbus Acquisition Corp Announces Adjournment of Reconvened Extraordinary General Meeting of the Shareholders

Columbus Acquisition Corp Announces Adjournment of Reconvened Extraordinary General Meeting of the Shareholders

Columbus Acquisition Corp, a US-based blank check company (SPAC), announced the adjournment of its reconvened Extraordinary General Meeting without conducting any business. The meeting is rescheduled for September 30, 2026, to further consider approving a proposed business combination with WISeSat.Space Corp. Shareholders retain voting rights from …

Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis

Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis

Nutriband Inc.'s CEO Gareth Sheridan is featured in a new documentary by Nick Shirley that examines America's opioid crisis. Sheridan discusses Nutriband's AVERSA™ abuse-deterrent transdermal platform designed to reduce opioid misuse and diversion while maintaining access for patients in need. The technology targets high-risk medications like fenta…

XCOM RAN Named “Warehouse Technology Innovation of the Year” in SupplyTech Breakthrough Awards

XCOM RAN Named “Warehouse Technology Innovation of the Year” in SupplyTech Breakthrough Awards

Globalstar's XCOM RAN, a next-generation private 5G wireless solution designed for warehouse automation and industrial AI, has been awarded 'Warehouse Technology Innovation of the Year' at the SupplyTech Breakthrough Awards. The solution offers high network capacity, ultra-low latency, and simplified deployment, supporting advanced automation techn…

VEON’s Beeline Kazakhstan Becomes First Operator in Country to Launch Starlink's Satellite to Mobile Service

VEON’s Beeline Kazakhstan Becomes First Operator in Country to Launch Starlink's Satellite to Mobile Service

VEON Ltd., via its subsidiary Beeline Kazakhstan, has launched the world's first satellite-to-mobile service with Starlink Mobile, enabling direct smartphone connectivity in cellular dead zones across Kazakhstan. This service enhances coverage in remote and disaster-affected areas without requiring special equipment, integrating seamlessly into Bee…

Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options

Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options

Arcutis Biotherapeutics announced a new awareness campaign, Skin to Believe In, featuring Simone Biles sharing her personal experience with seborrheic dermatitis and eczema. The campaign highlights ZORYVE (roflumilast), Arcutis's leading topical, steroid-free treatment for inflammatory skin conditions. Clinical data show significant efficacy with Z…

Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy

Ernexa Therapeutics Selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa, Highlighting ERNA-101 and Focused Oncology Strategy

Ernexa Therapeutics has been selected for the Emerging Track at the 2026 Cell & Gene Meeting on the Mesa. CEO Sanjeev Luther will present the company's off-the-shelf induced mesenchymal stem cell (iMSC) platform and its lead oncology candidate ERNA-101 targeting platinum-resistant ovarian cancer. Preclinical studies demonstrate promising tumor clea…

Western Digital: A Cash-Generating Anchor Through Macro Volatility

Western Digital: A Cash-Generating Anchor Through Macro Volatility

Western Digital is generating robust free cash flow, showing double-digit revenue growth and returning capital to shareholders even as macro sentiment stumbles. With a market cap near $164B, FCF of $3.51B, and solid guidance into fiscal Q1 2027, this trade targets upside from current levels while maintaining a clear stop for rising macro risk.

Inspired Provides Update on Brazil Regulatory Developments

Inspired Provides Update on Brazil Regulatory Developments

Inspired Entertainment reports that Brazil's new prohibition on regulated online betting and gaming operations is expected to significantly impact its revenue from the country, particularly its growing digital business. The company estimates a $3 million reduction in Q4 2026 revenue if the ban remains through year-end. While legal challenges and le…

Acuity Inc. Appoints Nick Tzitzon to its Board of Directors

Acuity Inc. Appoints Nick Tzitzon to its Board of Directors

Acuity Inc. has appointed Nick Tzitzon, Vice Chairman of ServiceNow and AI Institute leader, as an Independent Director to its Board. The addition expands the board from nine to ten members and is expected to enhance the company’s strategy in leveraging AI and digital transformation in industrial technology sectors.

Amaze Holdings (NYSE: AMZE) Executes Binding LOI to Acquire BullionFX | Alchemy, a Decentralized Gold-Backed Financial Ecosystem Valued at US$155 Million

Amaze Holdings (NYSE: AMZE) Executes Binding LOI to Acquire BullionFX | Alchemy, a Decentralized Gold-Backed Financial Ecosystem Valued at US$155 Million

Amaze Holdings announces a binding LOI to acquire BullionFX and its decentralized gold-backed financial ecosystem Alchemy for approximately $155 million in stock. The acquisition aims to strategically expand Amaze beyond creator commerce into the growing gold-backed digital asset and stablecoin market, leveraging BullionFX's Ethereum-based Layer 2 …